Tri Chemical Laboratories Inc (22E) fair value: what the stock is really worth
As of Oct 26, 2026: fair value (intrinsic value) of Tri Chemical Laboratories Inc stock €15.17, price €16.44, upside -7.7%, quality 53 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Fair value above price?No
Good quality?Yes
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 27, 2026.
How to read this chart
55‑month range €11.21 – €30.28 · fair‑value band €11.56 – €18.78 · the €16.44 price screens above the €15.17 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 27, 2026.
Follow Tri Chemical Laboratories in your weekly email
Every Wednesday you see whether Tri Chemical Laboratories is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Tri Chemical Laboratories Inc. develops, manufactures, and sells high-purity chemicals for semiconductor manufacturing in Japan, Taiwan, China, South Korea, and internationally. The company offers Si semiconductors, coating, optical fiber, compound semiconductor, and reagents.
Show moreShow less
It also provides analyses services, such as purity measurement, impurity measurement, and thermal stability tests, film-forming tests, stainless steel container with valve and overseas specifications, metal seamless container for high pressure gas, sealed glass ampoule, polyethylene container, glass screw cap bottle, glass vials bottle, and pipe cleaning.
Tri Chemical Laboratories Inc. was incorporated in 1978 and is headquartered in Uenohara, Japan.
Stock analysis
Tri Chemical Laboratories Inc (22E) currently trades at €16.44, while our model-based Fair Value estimate is €15.17, so the stock looks roughly fairly valued today (gap 8.4%).
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of €30.34 per share, and 5 of the 16 models we run sit above the €16.44 price.
Bear case: the Dividend Discount group reads lowest at €2.01, and 11 of the 16 models stay below the price. Data coverage for this calculation is high.
Scenario range: €11.56 (bear) to €18.78 (bull), the price of €16.44 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 53/100 (solid quality), in the Basic Materials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Tri Chemical Laboratories Inc reported revenue of ¥23.9B in FY2026 versus ¥11.6B in FY2022, a compound +19.9%/yr. Reported net income was ¥5.5B in FY2026, compounding +7.7%/yr from FY2022.
Key figures
Market cap €534M Small · P/E ratio 15.7 · P/S ratio 3.62 · EPS (TTM) €1.05 · Dividend yield 1.2% · Net margin 23.1% · Return on equity 17.1% · Return on assets (EBIT) 10.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 76 out of 100 (low confidence).
What moves the price
The share trades about 26% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −55% fair-value upside, at −8%, 22E screens cheaper than that median.
Fair Value models
Bear€11.56Fair Value €15.17Bull€18.78
Price €16.44 · Upside -7.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2026 figures (about 9 months old). Earnings retained since then (€0.6274 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+26.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.1%
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in JPY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in JPY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+7.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+6.1%
Dividend (yield on the price)1.2%
Profit margin 2022 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.26% → 25%
Compare Tri Chemical Laboratories Inc with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 724 stocks
Beats the industry median on 9/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score53 · Below median
Fair Value upside−7.7% · Above median
Profitability
Return on equity (12 months)17.1% · Top 25%
Return on assets11.7% · Top 25%
Net margin (12 months)23.3% · Top 25%
Operating margin (12 months)24.5% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)24.3% · Above median
Dividend yield (12 months)1.2% · Below median
Balance sheet
Debt / equity0.09× · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Tri Chemical Laboratories Inc Fair Value". https://www.fairvalue-calculator.com/stock/22E
Frequently asked questions
Is Tri Chemical Laboratories Inc (22E) overvalued or undervalued?
As of Oct 27, 2026, our model estimates a fair value of €15.17 versus a price of €16.44, about −8% upside (fairly valued).
What is the fair value of 22E?
Our model-based fair value for Tri Chemical Laboratories Inc is €15.17 (as of Oct 27, 2026), built from audited fundamentals. The current price: €16.44.
What is the quality score of 22E?
Tri Chemical Laboratories Inc has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Tri Chemical Laboratories Inc (22E)?
Our model-based price target is the fair value of €15.17 (as of Oct 27, 2026) from 16 valuation models. Cautious scenario €11.56, optimistic scenario €18.78. It is a calculation from audited fundamentals, not an analyst target.
What is the Tri Chemical Laboratories Inc stock forecast for 2026?
Our models put fair value at €15.17, about −8% upside versus a price of €16.44 (fairly valued). Cautious scenario €11.56, optimistic scenario €18.78. The calculation is refreshed regularly with new filings.
What is the revenue of Tri Chemical Laboratories Inc (22E)?
Tri Chemical Laboratories Inc reported trailing-twelve-month revenue of about ¥26.2B (latest available figure, as of Oct 27, 2026).
Does Tri Chemical Laboratories Inc pay a dividend?
Tri Chemical Laboratories Inc currently shows a dividend yield of 1.21% relative to its recent price (as of Oct 27, 2026).
What is the intrinsic value of Tri Chemical Laboratories Inc (22E)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Tri Chemical Laboratories Inc it is €15.17 per share (as of Oct 27, 2026), against a price of €16.44. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Tri Chemical Laboratories Inc stock overvalued or undervalued in 2026?
As of Oct 27, 2026, 22E trades above its calculated fair value: price €16.44, fair value €15.17, a gap of about −8% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 22E?
No. The price is what the market pays today (€16.44); the fair value is what the company's own numbers justify (€15.17). For Tri Chemical Laboratories Inc the two are €1.27 per share apart. That gap is exactly why we show both numbers side by side.
How much is Tri Chemical Laboratories Inc worth?
The market values Tri Chemical Laboratories Inc at about €534M (market capitalisation, as of Oct 27, 2026). Per share that is €16.44; our models calculate a fair value of €15.17 per share.
What do the bullish and bearish scenarios say about 22E?
Our models span a range for Tri Chemical Laboratories Inc: cautious scenario €11.56, base €15.17, optimistic €18.78 per share (as of Oct 27, 2026, price €16.44). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 22E?
Tri Chemical Laboratories Inc trades at a price-to-earnings ratio of 15.7 (as of Oct 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €15.17 is built from several models across several years. Other multiples: P/B 2.6, P/S 3.6, EV/EBITDA 10.2.
How solid is the balance sheet of Tri Chemical Laboratories Inc (22E)?
Balance-sheet figures for Tri Chemical Laboratories Inc (as of Oct 27, 2026): return on equity 17.1%, debt of 0.09 per unit of equity. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is 22E from its 52-week high?
Tri Chemical Laboratories Inc trades at €16.44, about 26% below its 52-week high of €22.20 and 18% above the low of €13.95 (as of Oct 23, 2026). Distance from the high says nothing about value: that is what the fair value of €15.17 is for.
Which stocks are comparable to Tri Chemical Laboratories Inc?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Tri Chemical Laboratories Inc stock attractive at the current price?
The data as of Oct 27, 2026: price €16.44, calculated fair value €15.17 (−8%), Quality Score 53/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 22E calculated?
We run Tri Chemical Laboratories Inc through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €15.17, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 12.7 % above its aggregate fair value. Tri Chemical Laboratories Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Tri Chemical Laboratories Inc (22E)?
The closing price on Oct 26, 2026 was €16.44. Our model-based fair value is €15.17, about −8% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Tri Chemical Laboratories Inc right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the upper half of our model range, so the margin of safety is thin. The data supports the verdict: every model runs on fully documented inputs.
Key figures of Tri Chemical Laboratories Inc
How large is the market capitalisation of Tri Chemical Laboratories Inc (22E)?
The market capitalisation of Tri Chemical Laboratories Inc is €534M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Tri Chemical Laboratories Inc (22E)?
The price-to-sales ratio of Tri Chemical Laboratories Inc is 3.62 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Tri Chemical Laboratories Inc (22E)?
Earnings per share at Tri Chemical Laboratories Inc are €1.05 (price ÷ EPS = P/E 15.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Tri Chemical Laboratories Inc (22E)?
The dividend yield of Tri Chemical Laboratories Inc is 1.2% (payout 18.9%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Tri Chemical Laboratories Inc (22E)?
The net margin of Tri Chemical Laboratories Inc is 23.1% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Tri Chemical Laboratories Inc (22E)?
The return on equity (ROE) of Tri Chemical Laboratories Inc is 17.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Tri Chemical Laboratories Inc (22E)?
On an EBIT basis the return on assets of Tri Chemical Laboratories Inc is 10.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Tri Chemical Laboratories Inc (22E)?
The operating margin of Tri Chemical Laboratories Inc is 24.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Tri Chemical Laboratories Inc (22E)?
Revenue at Tri Chemical Laboratories Inc is growing +24.3% versus a year earlier (3y avg +20.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Tri Chemical Laboratories Inc (22E)?
Earnings per share at Tri Chemical Laboratories Inc are growing −3.2% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Tri Chemical Laboratories Inc (22E) generate?
The free cash flow of Tri Chemical Laboratories Inc is −¥2.5B (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed
Watch Tri Chemical Laboratories Inc in the live analysis
One click puts Tri Chemical Laboratories Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Broad data
Oct 27, 2026